Vancouver, Canada

Michel Roberge

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: The University of British Columbia, University of Alberta, Other. Active years: 2000-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Roberge. Retrieved from https://idiyas.com/inventor/michel-roberge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2000-2010

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Michel Roberge

Introduction

Michel Roberge is a notable inventor based in Vancouver, Canada, recognized for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, Roberge has focused on developing innovative solutions for various medical conditions.

Latest Patents

Among his latest patents, Roberge has developed indoleamine 2,3-dioxygenase (IDO) inhibitors. These inhibitors are crucial for treating conditions characterized by pathology in the IDO-mediated tryptophan metabolic pathway. Such conditions may include suppression of T-cell mediated immune response, depletion of tryptophan, and accumulation of tryptophan degradation products. Specific diseases targeted by these inhibitors include cataracts, neurodegenerative disorders, mood disorders, cancer, and various bacterial and viral infections. The IDO inhibitors developed by Roberge feature substituted naphthalene and anthracene diones, with novel compounds including taurine-substituted naphthaquinone structures. Additionally, he has worked on biologically active peptides and compositions derived from hemiasterlin or Geodiamolide G, which exhibit anti-mitotic activities useful in cancer treatment.

Career Highlights

Roberge's career has been marked by his association with prestigious institutions such as the University of British Columbia and the University of Alberta. His work in these academic environments has

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…